| If this is not your name, click here. | | |
| | Contact Us | Order Now | Journals | Bookstore | Register a colleague | | |
| | | ![]() Synvisc Approved In Australia For Osteoarthritis RIDGEFIELD, NJ -- Dec. 18, 1998 -- The Australian Therapeutic Goods Administration has approved Biomatrix, Inc.’s Synvisc(R) for the treatment of pain in osteoarthritis of the knee. The company also announced that it has received approvals to market Synvisc in Malaysia, Singapore and Thailand. Synvisc is an intra-articular treatment for osteoarthritis of the knee, a painful and debilitating joint disease in which the elastoviscous properties of the synovial fluid in the knee joint diminish, resulting in less protection and shock absorption. It is used for patients who do not get adequate relief from simple painkillers (for example, acetaminophen) or from exercise and physical therapy. Related Links: Synvisc, Biomatrix, Inc.
|